Loghavi, S., Zang, C., Li, Z., Hammond, D., Chien, K., Bataller, A., Bazinet, A., Sasaki, K., Jabbour, E., DiNardo, C., Short, N., Issa, G., Pemmaraju, N., Kadia, T., Ravandi, F., Daver, N., Borthakur, G., Kanagal-Shamanna, R., Wei, P., Wang, S., Wang, W., Fang, H., Tang, G., Pierce, S., Bueso-Ramos, C., Medeiros, L. J., Kantarjian, H., Garcia-Manero, G., Montalban-Bravo, G. (2025). Multimodal assessment of chronic myelomonocytic leukemia with extramedullary involvement reveals RAS pathway activation, adverse outcomes and epithelial-mesenchymal transition. Blood. https://doi.org/10.1182/blood-2025-3848